Replies to post #514336 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Neither Optune nor DCVax-L are screening for methylated tumor patients or any mutations.

Optune provides more than HOPE, Optune had OS of 13% in 5 years, a rate DCVax-L fanboys are touting as "breakthrough", "landmark", etc. Did you miss that?